GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Simris Alg AB (OSTO:SIMRIS B) » Definitions » Cyclically Adjusted PB Ratio

Simris Alg AB (OSTO:SIMRIS B) Cyclically Adjusted PB Ratio : 0.18 (As of Jun. 26, 2025)


View and export this data going back to 2016. Start your Free Trial

What is Simris Alg AB Cyclically Adjusted PB Ratio?

As of today (2025-06-26), Simris Alg AB's current share price is kr0.225. Simris Alg AB's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 was kr1.28. Simris Alg AB's Cyclically Adjusted PB Ratio for today is 0.18.

The historical rank and industry rank for Simris Alg AB's Cyclically Adjusted PB Ratio or its related term are showing as below:

OSTO:SIMRIS B' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.06   Med: 0.07   Max: 0.16
Current: 0.16

During the past years, Simris Alg AB's highest Cyclically Adjusted PB Ratio was 0.16. The lowest was 0.06. And the median was 0.07.

OSTO:SIMRIS B's Cyclically Adjusted PB Ratio is ranked better than
84.21% of 684 companies
in the Biotechnology industry
Industry Median: 1.49 vs OSTO:SIMRIS B: 0.16

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Simris Alg AB's adjusted book value per share data for the three months ended in Mar. 2025 was kr-0.002. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is kr1.28 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Simris Alg AB Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Simris Alg AB's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Simris Alg AB Cyclically Adjusted PB Ratio Chart

Simris Alg AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 0.06

Simris Alg AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 0.06 0.09

Competitive Comparison of Simris Alg AB's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, Simris Alg AB's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Simris Alg AB's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Simris Alg AB's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Simris Alg AB's Cyclically Adjusted PB Ratio falls into.


;
;

Simris Alg AB Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Simris Alg AB's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=0.225/1.28
=0.18

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Simris Alg AB's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Simris Alg AB's adjusted Book Value per Share data for the three months ended in Mar. 2025 was:

Adj_Book=Book Value per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=-0.002/132.8245*132.8245
=-0.002

Current CPI (Mar. 2025) = 132.8245.

Simris Alg AB Quarterly Data

Book Value per Share CPI Adj_Book
201506 0.000 99.995 0.000
201509 0.000 100.228 0.000
201512 2.575 100.276 3.411
201603 0.000 100.751 0.000
201606 3.584 101.019 4.712
201609 3.423 101.138 4.495
201612 3.102 102.022 4.039
201703 2.836 102.022 3.692
201706 2.609 102.752 3.373
201709 2.334 103.279 3.002
201712 2.080 103.793 2.662
201803 1.758 103.962 2.246
201806 1.608 104.875 2.037
201809 2.259 105.679 2.839
201812 1.335 105.912 1.674
201903 1.164 105.886 1.460
201906 0.887 106.742 1.104
201909 0.634 107.214 0.785
201912 0.850 107.766 1.048
202003 0.691 106.563 0.861
202006 0.671 107.498 0.829
202009 0.466 107.635 0.575
202012 0.398 108.296 0.488
202103 0.336 108.360 0.412
202106 0.279 108.928 0.340
202109 0.186 110.338 0.224
202112 0.153 112.486 0.181
202203 0.117 114.825 0.135
202206 0.196 118.384 0.220
202209 0.170 122.296 0.185
202212 0.122 126.365 0.128
202303 0.073 127.042 0.076
202306 0.019 129.407 0.020
202309 0.091 130.224 0.093
202312 0.074 131.912 0.075
202403 0.050 132.205 0.050
202406 0.021 132.716 0.021
202409 0.003 132.304 0.003
202412 0.009 132.987 0.009
202503 -0.002 132.825 -0.002

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Simris Alg AB  (OSTO:SIMRIS B) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Simris Alg AB Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Simris Alg AB's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Simris Alg AB Business Description

Traded in Other Exchanges
N/A
Address
Herrestadsvagen 24A, Hammenhog, SWE, 276 50
Simris Alg AB is a biotechnology company, engaged in research, development and production of bioactive substances from microalgae, for nutraceutical, cosmeceutical and pharmaceutical applications. The company's technology provides access to bioactive substances with novel functions, while replacing unsustainable raw materials from endangered marine species and ecosystems. Its first commercialised range is a series of omega-3 health supplements marketed under the company's own brand.

Simris Alg AB Headlines

No Headlines